The Earnings Report in the May 3, 1995, issue of BioWorld Todaytransposed numbers for Sugen Inc. for the three months that ended onMarch 31. The company had revenues of $3,427,000, an increase of143 percent from the first quarter in 1994. It had a net loss of$1,418,000, or 16 cents per share, compared to $2,768,000, or 50cents per share, in 1994. And its research and development expensesincreased 34 percent to $4,955,000.

(c) 1997 American Health Consultants. All rights reserved.

No Comments